The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.00
Bid: 37.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.405%)
Open: 38.00
High: 38.00
Low: 38.00
Prev. Close: 38.00
EMR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

27 Jul 2023 07:00

RNS Number : 3272H
Empresaria Group PLC
27 July 2023
 

27 July 2023

 

Empresaria Group plc

("Empresaria" or the "Group")

 

Trading Update and Notice of Results

 

 

Challenging market conditions continuing to impact results

Empresaria (AIM: EMR), the global specialist staffing group, today provides a trading update ahead of announcing its interim results on 22 August 2023.

 

Trading update

 

· H1 net fee income down 9% year-on-year to £29.7m (down 10% in constant currency)

· Adjusted net debt slightly increased to £8.7m (31 December 2022: £7.9m) with headroom slightly increased to £18.4m

· Anticipated improvements to trading conditions have not been seen and we now do not expect these to significantly change in the second half of 2023. 

· Full year adjusted profit before tax is expected to be materially lower than market expectations

 

As highlighted in the trading update on 23 May 2023, the softening of demand and slowing of hiring decisions seen across the Group's businesses in the second half of 2022 have continued into 2023. These difficult market conditions have been experienced across the Group, particularly in the US. The greatest net fee income impact has been on permanent recruitment which was down 24% year-on-year with temporary and contract down 8%.

 

Our Offshore Services operation, where there is a 28% non-controlling interest, delivered year-on-year net fee income growth of 15% against the first half of 2022. Sales to UK clients, which primarily support the Healthcare sector, have continued to grow strongly, however sales to our US clients, the majority of which support the IT sector, have continued to be impacted by the fall in client demand seen in the second half of 2022.

 

The Group has already implemented a number of targeted measures to manage its cost base, including reductions in headcount, and we continue to keep costs under review. However, given the ongoing trading conditions, which we no longer expect to improve significantly in the second half of the year, full year adjusted profit before tax is now expected to be approximately £5m.

 

Financial position

 

Adjusted net debt as at 30 June 2023 increased slightly to £8.7m (31 December 2022: £7.9m) reflecting trading performance and a normal H1 weighting of certain key cash outflows. Headroom has increased slightly to £18.4m reflecting improved efficiency in the management of cash balances.

 

Rhona Driggs, CEO of Empresaria, commented:

 

"We continue to face challenging market conditions which developed through the second half of 2022 and remained throughout the first half of 2023. We have not seen the anticipated signs of sustained improvement as client confidence remains low and candidates continue to be reluctant to move in the current environment. With the ongoing macro-economic uncertainty, we now expect these factors to continue to have an adverse impact on the Group's profits in the second half of 2023.

 

We have taken action on our cost base and will continue to maintain tight control over costs while ensuring that we are able to maximise opportunities as and when market confidence returns. While we are disappointed with these results, we are continuing to execute on our strategic initiatives and are confident in the medium and longer-term prospects of the Group."

 

Investor presentation

 

In line with Empresaria's commitment to ensuring appropriate communication structures are in place for all sections of its shareholder base, management will deliver an online results presentation open to all existing and potential investors via the Investor Meet Company platform on Tuesday 22 August 2023 at 4:30pm UK time.

 

Questions can be submitted pre-event through the platform or at any time during the live presentation. Management may not be in a position to answer every question it receives but will address those it can while remaining within the confines of information already disclosed to the market.

 

Q&A responses will be published at the earliest opportunity on the Investor Meet Company platform.

 

Investors can sign up for free via: https://www.investormeetcompany.com/empresaria-group-plc/register-investor. Those who have already registered and requested to meet the Company will be automatically invited.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

- Ends -

 

Enquiries:

Empresaria Group plc Rhona Driggs, Chief Executive OfficerTim Anderson, Chief Financial Officer

via Alma PR

Singer Capital Markets (Nominated Adviser and Joint Broker) Shaun Dobson / James Moat

020 7496 3000

Cenkos Securities plc (Joint Broker) Katy Birkin / Charlie Combe (Corporate Finance)

Michael Johnson / Jasper Berry (Sales)

020 7397 8900

Alma PR (Financial PR) Sam Modlin / Rebecca Sanders-Hewett / Pippa Crabtree / Hilary Buchanan

020 3405 0205empresaria@almapr.com

 

Notes for editors:

§ Empresaria Group plc is a global specialist staffing group offering temporary and contract recruitment, permanent recruitment and offshore recruitment services across 6 sectors: Professional, IT, Healthcare, Property, Construction and Engineering, Commercial and Offshore Recruitment Services.

 

§ Empresaria operates from locations across the world including the 4 largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.

 

§ Empresaria is listed on AIM under ticker EMR. For more information visit empresaria.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDRBXDDGXL
Date   Source Headline
23rd Apr 202411:23 amRNSPDMR Shareholding
19th Apr 202412:36 pmRNSPDMR Shareholding
11th Apr 20247:00 amRNSAnnual Report and Accounts and Notice of AGM
26th Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20247:00 amRNSNotice of Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
18th Dec 202312:54 pmRNSTransaction in Own Shares
11th Dec 20233:11 pmRNSTransaction in Own Shares
7th Dec 20238:12 amRNSTransaction in Own Shares
5th Dec 20238:03 amRNSTransaction in Own Shares
30th Nov 202310:49 amRNSHolding(s) in Company
21st Nov 20237:00 amRNSTrading Update
8th Nov 202311:02 amRNSTransaction in Own Shares
27th Oct 20238:41 amRNSTransaction in Own Shares
17th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 20238:39 amRNSTransaction in Own Shares
5th Oct 202310:14 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
28th Sep 20238:27 amRNSTransaction in Own Shares
22nd Sep 20238:21 amRNSTransaction in Own Shares
18th Sep 20239:05 amRNSTransaction in Own Shares
12th Sep 20239:16 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSPDMR Dealing, Exercise of Share Options
22nd Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSLaunch of LMA Recruitment in the US
27th Jul 20237:00 amRNSTrading Update and Notice of Results
19th Jun 20238:20 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
23rd May 20231:18 pmRNSResult of AGM
23rd May 20237:00 amRNSTrading Update
16th May 20237:00 amRNSTransaction in Own Shares
2nd May 20236:25 pmRNSDirector/PDMR Shareholding
2nd May 20234:26 pmRNSTransaction in Own Shares
28th Apr 20233:50 pmRNSPDMR Dealing, Exercise of Share Options
26th Apr 20237:00 amRNSCompany LTIP Awards
20th Apr 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
30th Mar 202310:15 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSFinal Results
20th Mar 20233:05 pmRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSAppointment of Independent Non-Executive Director
26th Jan 20237:00 amRNSTrading Update
16th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
15th Dec 20222:49 pmRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:18 amRNSTransaction in Own Shares
7th Dec 20228:34 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20228:24 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.